Advisory Board and Editors Oncology
Andrew R Gray
I am a biostatistician in the Biostatistics Centre at the University of Otago, a role I have held since 2004. Most of my work involves collaborating on a wide range of research projects in the health sciences, particularly in paediatric obesity, sleep, and physical activity; respiratory epidemiology, mostly asthma and COPD; dentistry; and health systems. I also work on statistical methods research, mostly topics inspired by these collaborations.
Prior to my current position I was a software metrics and machine learning researcher in the Department of Information Science at the same institution.
Michael R. Green
HHMI Investigator and Professor of Molecular Medicine and Director of the Program in Gene Function and Expression at the University of Massachusetts Medical School.
Michael R. Green received his MD and PhD degrees from Washington University School of Medicine in 1981. He was awarded a Helen Hay Whitney Postdoctoral Fellowship to perform postdoctoral work at Harvard University in the Department of Biochemistry and Molecular Biology. He became a faculty member in that department at Harvard in 1984, where he remained until he joined the Program in Molecular Medicine at the University of Massachusetts Medical School in 1990. He has been the recipient of the Searle Scholar Award, the Presidential Young Investigators Award, the McKnight Neuroscience Award, and in 1993 was invited to deliver a Harvey Lecture. In 1994 Dr. Green was made an Investigator of the Howard Hughes Medical Institute.
Jun-Lin Guan
Professor of Internal Medicine and of Cell and Developmental Biology at University of Michigan Medical School. Fellow of the American Association for the Advancement of Science.
Fanglin Guan
Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.
Deniz Can Güven
Dr. Deniz Can Güven is a medical oncologist in the Department of Medical Oncology at Hacettepe University.
His primary research interest focuses on immuno-oncology.
Jari K Haukka
8/2009 -present Senior Lecturer, University of Helsinki
4/2011 - 1/2017 Chief Science Officer, Chair of the Board, EPID Research Oy
4/2010 - present Member of National Subcommittee on Medical Research Ethics
4/2010 - 3/2011 Chief Executive Officer, EPID Research Oy
10/1988 - 11/2016 Senior Scientist, The National Institute of Health and Welfare, Finland
5/2008 - 5/2009 Scientist, Team leader, International Agency for Researcher on Cancer (WHO/IARC), Lyon France
1/2008 - 8/2008 Professor of biometry, University of Tampere
2006 - 2007 Senior Scientist, National Institute of Public Health, Finland
2005 Team Leader, Epidemiologist, Geneos Oy
2003 - 2005 Head, Finnish Information Centre for Register Research
1999 - 2003 Senior Scientist, National Institute of Public Health
1988 - 1999 Senior Scientist, Statistician, National Institute of Public Health
1985 - 1988 Soil Biologist, MTT Agrifood Research Finland, Jokioinen
1985 - 1986 Programmer, MTT Agrifood Research Finland
Jian He
Dr. He obtained her Ph.D. degree from a joint Ph.D. program in Jilin University and University of California, San Diego under Prof. Shu Chien which is the Academician of National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and American Academy of Arts and Sciences of US. Dr. He then worked in Los Alamos National Laboratory (LANL) in the United States, Chinese Academy of Sciences and Shanghai Jiao Tong University in China. In 2019, Dr. He joined the Center for Single-Cell Omics in Shanghai Jiao Tong University School of Medicine as the core director of the genomics core.
Dr. He’s research focused on developing more sophisticated technology of single-cell multiple-omics analysis, using systems biology strategies to elucidate the underlying mechanism of major diseases, especially oncology and discover novel biomarkers, and AI Drug Screening. As of June. 2022, Dr. He has authored 60 high-quality scholarly articles including 25 first-authored and correspondence author papers, which have been extensively cited. Also, Dr. He has filed 15 patents. Also, she has been awarded research grants and awards from National Natural Science Foundation, China Postdoctoral Science Special Foundation, and so on. Dr. He was invited to contribute review articles by highly influential research journals in her field and give oral presentations at national and international conferences. Dr. He also serves as an article reviewer of numerous notable international journals.
Altijana Hromić-Jahjefendić
Dr. Altijana Hromić-Jahjefendić is an associate professor at the Genetics and Bioengineering Department at International University of Sarajevo, Bosnia and Herzegovina. She obtained her bachelor's degree in chemistry and master's degree in Biochemistry and Molecular Biomedicine at Graz University of Technology, Austria. After that she worked for Austrian Center of Industrial Biotechnology and continued to pursue her PhD degree in Biochemistry and Molecular Biomedicine with the focus on Structural biology. Since 2018. she works as professor at International University of Sarajevo at the Genetics and Bioengineering Department. She authored many scientific publications with international colleagues in the field of COVID-19 and cancer research.
Lei Huang
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Md Asiful Islam
Dr Asiful is currently working as a research fellow at the WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, UK.
Dr Md Asiful Islam completed his PhD (Fast Track, Passed with Grade 1, Pass without correction) in Genetics & Autoimmunity from Human Genome Centre, Universiti Sains Malaysia (November 2018) under Professor Dr Siew Hua Gan following completing BSc in Biochemistry & Molecular Biology (Jahangirnagar University, Dhaka, Bangladesh). He achieved Malaysia International Scholarship and USM Vice-Chancellor Award during his PhD and working as a Senior Lecturer at the Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia from 2019 till 2022.
Besides PeerJ, he has been working as an Academic Editor for Nature Scientific Data, PLOS ONE, BMC Rheumatology, Autoimmunity Highlights, Endocrine, Metabolic & Immune Disorders - Drug Targets, Current Immunology Reviews and Current Rheumatology Reviews.
Dr Asiful's research interest covers different research areas of Medical Sciences including Haematology, Immunology, Pharmacology, Molecular Genetics and Neurosciences. He is currently focused on developing and executing systematic reviews and meta-analyses decoding various research questions of Medical Sciences.
Jose MG Izarzugaza
Associate Professor at the Technical University of Denmark (DTU). As a senior scientist in Prof. Søren Brunak's group at the Center for Biological Sequence Analysis (CBS), I have a profound interest in different aspects of next generation sequencing (NGS) data analysis. This covers a broad spectrum of scenarios and applications. Actively involved in the Genome Denmark initiative, with two main goals: to assemble and annotate the first draft of the Danish reference genome and to identify viruses driving cancer. Other current projects include the prediction of the pathogenicity of mutations in the protein kinase superfamily for the TCGA/ICGC Pancancer initiative.
Jayashree Kalpathy-Cramer
Research interests include the use of image processing and machine learning techniques for medical image analysis and retrieval, imaging for radiation therapy, survival analysis for cancer, information retrieval, and statistical modeling.